All heterologous antigens articles

  • H1N1_Influenza_Virus_Particles_(8411599236)
    News

    Influenza virus platforms: New hope for vaccines and cancer immunotherapy

    2026-05-18T11:06:00Z

    Influenza virus is now being engineered to carry foreign genes and reduce virulence, serving not only for next-generation influenza vaccines but also as delivery vectors for heterologous antigens against other infections and cancers, supported by its ability to trigger robust mucosal and systemic immune responses.